NorthWest Biotherapeutics Inc (NWBO)

[seekinganswers]

"That wasn’t the road I hoped you go down". . 🤣
OK Smarty pants..
Specials has been approved for about 10 years now. Please tell me how many patients were treated, their level of disease, the cost per patient and the peer reviewed clinical results.
Thanks, I'll wait.
By the way ---- I'm not the only one.
Indeed, two of the comparator studies were reflecting community trials that did allow radiological progression at the time of randomization and for the extent of resection only required that at least a tumor block of 1 cm3 was available for translational research.6,7 The trial on tumor treating fields (TTF) did not restrict inclusion because of steroid use or extent of resection.8 Two other used trials are also vaccine approaches, with similar precautions on the extent of resection and steroid use. This resulted in important differences between these trials in exclusion rates for progression during the radio-chemotherapy phase: the two trials that reflected a community approach and the TTF trial excluded between 2 and 8% of patients registered into the trial for progression during concomitant radio-chemotherapy, whereas no less than 18% of patients registered into the DCVax-L trial were excluded for this reason.

https://pmc.ncbi.nlm.nih.gov/articles/PMC10076936/